Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Hankey

Showing results (31-40 of 37) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 37 results.
Cancer Immunology, Immunotherapy : CII|February 13, 2024
Treatment of secondary CNS lymphoma using CD19-targeted chimeric antigen receptor (CAR) T cellsKathryn Kline, Tim Luetkens, Rima Koka, et al.
Blood Advances|July 26, 2024
Coordinated antiviral immune response in a patient with myeloma and systemic adenovirus infection post-BCMA CAR T cellsMehmet H Kocoglu, Tim Luetkens, Jacqueline T Bork, et al.
Communications Biology|December 17, 2021
Deep dissection of the antiviral immune profile of patients with COVID-19Djordje Atanackovic, Stephanie V Avila, Forat Lutfi, et al.
Haematologica|October 16, 2025
CNS infiltration by zamtocabtagene autoleucel tandem CD20/CD19 CAR T cells leading to complete remission in a patient with primary CNS lymphomaNancy M Hardy, Jean A Yared, Tim Luetkens, et al.
Neuroepidemiology|April 15, 2010
Rationale and design of INTERSTROKE: a global case-control study of risk factors for strokeM O'Donnell, D Xavier, C Diener, et al.
Haematologica|September 7, 2023
Immune-mediated facial nerve paralysis in a myeloma patient post B-cell maturation antigen-targeted chimeric antigen receptor T cellsYamini K Kathari, Haroon Ahmad, Michael E Kallen, et al.
Nature Communications|July 3, 2025
Immune correlates of anti-BCMA CAR-T products idecabtagene vicleucel and ciltacabtagene autoleucel in a real-world cohort of patients with multiple myelomaDjordje Atanackovic, Tim Luetkens, Dina Schneider, et al.
Pageof 4

Showing results (31-40 of 37) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 37 results.
Cancer Immunology, Immunotherapy : CII|February 13, 2024
Treatment of secondary CNS lymphoma using CD19-targeted chimeric antigen receptor (CAR) T cellsKathryn Kline, Tim Luetkens, Rima Koka, et al.
Blood Advances|July 26, 2024
Coordinated antiviral immune response in a patient with myeloma and systemic adenovirus infection post-BCMA CAR T cellsMehmet H Kocoglu, Tim Luetkens, Jacqueline T Bork, et al.
Communications Biology|December 17, 2021
Deep dissection of the antiviral immune profile of patients with COVID-19Djordje Atanackovic, Stephanie V Avila, Forat Lutfi, et al.
Haematologica|October 16, 2025
CNS infiltration by zamtocabtagene autoleucel tandem CD20/CD19 CAR T cells leading to complete remission in a patient with primary CNS lymphomaNancy M Hardy, Jean A Yared, Tim Luetkens, et al.
Neuroepidemiology|April 15, 2010
Rationale and design of INTERSTROKE: a global case-control study of risk factors for strokeM O'Donnell, D Xavier, C Diener, et al.
Haematologica|September 7, 2023
Immune-mediated facial nerve paralysis in a myeloma patient post B-cell maturation antigen-targeted chimeric antigen receptor T cellsYamini K Kathari, Haroon Ahmad, Michael E Kallen, et al.
Nature Communications|July 3, 2025
Immune correlates of anti-BCMA CAR-T products idecabtagene vicleucel and ciltacabtagene autoleucel in a real-world cohort of patients with multiple myelomaDjordje Atanackovic, Tim Luetkens, Dina Schneider, et al.
Pageof 4